###begin article-title 0
Genetic Association Analysis of the Functional c.714T>G Polymorphism and Mucosal Expression of Dectin-1 in Inflammatory Bowel Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: HSdV TSP LABJ MGN DJdJ. Performed the experiments: HSdV TSP JHvK RS EAF. Analyzed the data: HSdV TSP. Contributed reagents/materials/analysis tools: AAvB RKW BC RKL. Wrote the paper: HSdV TSP LABJ MGN DJdJ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 384 392 381 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 525 533 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 551 567 541 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 649 657 636 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 551 567 <span type="species:ncbi:5476">Candida albicans</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
Dectin-1 is a pattern recognition receptor (PRR) expressed by myeloid cells that specifically recognizes beta-1,3 glucan, a polysaccharide and major component of the fungal cell wall. Upon activation, dectin-1 signaling converges, similar to NOD2, on the adaptor molecule CARD9 which is associated with inflammatory bowel disease (IBD). An early stop codon polymorphism (c.714T>G) in DECTIN-1 results in a loss-of-function (p.Y238X) and impaired cytokine responses, including TNF-alpha, interleukin (IL)-1beta and IL-17 upon in vitro stimulation with Candida albicans or beta-glucan. The aim of the present study was to test the hypothesis that the DECTIN-1 c.714T>G (p.Y238X) polymorphism is associated with lower disease susceptibility or severity in IBD and to investigate the level of dectin-1 expression in inflamed and non-inflamed colon tissue of IBD patients.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
Paraffin embedded tissue samples from non-inflamed and inflamed colon of IBD patients and from diverticulitis patients were immunohistochemically stained for dectin-1 and related to CD68 macrophage staining. Genomic DNA of IBD patients (778 patients with Crohn's disease and 759 patients with ulcerative colitis) and healthy controls (n = 772) was genotyped for the c.714T>G polymorphism and genotype-phenotype interactions were investigated.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 260 268 260 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 438 446 438 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 128 136 <span type="species:ncbi:9606">patients</span>
###xml 322 330 <span type="species:ncbi:9606">patients</span>
Increased expression of dectin-1 was observed in actively inflamed colon tissue, as compared to non-inflamed tissue of the same patients. Also an increase in dectin-1 expression was apparent in diverticulitis tissue. No statistically significant difference in DECTIN-1 c.714T>G allele frequencies was observed between IBD patients and healthy controls. Furthermore, no differences in clinical characteristics could be observed related to DECTIN-1 genotype, neither alone, nor stratified for NOD2 genotype.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
Our data demonstrate that dectin-1 expression is elevated on macrophages, neutrophils, and other immune cells involved in the inflammatory reaction in IBD. The DECTIN-1 c.714T>G polymorphism however, is not a major susceptibility factor for developing IBD.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Sartor1">[1]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Xavier1">[2]</xref>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Tysk1">[3]</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD1</italic>
###xml 605 608 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Cho1">[4]</xref>
###xml 641 654 641 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2 (CARD15)</italic>
###xml 856 859 856 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Girardin1">[5]</xref>
###xml 861 864 861 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Inohara1">[6]</xref>
Inflammatory bowel disease (IBD), is an idiopathic, chronic, relapsing inflammatory disorder of the gastrointestinal tract. It is commonly accepted that IBD is caused by an exaggerated cell mediated immune response to intestinal microbiota in genetically susceptible individuals[1], [2]. IBD mainly involves two distinct diseases, which show some overlap: Crohn's disease (CD) and ulcerative colitis (UC). Genetic susceptibility is more pronounced in CD compared to UC[3]. Several susceptibility loci for developing CD have been identified in the past decades including the NOD2 gene within the IBD1 locus[4]. The established association of NOD2 (CARD15) with CD emphasizes the important role of the intestinal microbiota in the pathogenesis of CD, since NOD2 acts as an intracellular pattern recognition receptor (PRR) recognizing bacterial peptidoglycans[5], [6].
###end p 11
###begin p 12
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLEC7A</italic>
###xml 250 266 247 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 271 292 268 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 539 542 532 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Gross1">[7]</xref>
###xml 782 785 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Hsu1">[8]</xref>
###xml 989 992 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-LeibundGutLandmann1">[9]</xref>
###xml 1036 1041 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD9</italic>
###xml 1075 1079 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Zhernakova1">[10]</xref>
###xml 1095 1103 1084 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 1259 1263 1248 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Ferwerda1">[11]</xref>
###xml 1480 1488 1462 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1521 1537 1500 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 1537 1541 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Plantinga1">[12]</xref>
###xml 250 266 <span type="species:ncbi:5476">Candida albicans</span>
###xml 271 292 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 1521 1537 <span type="species:ncbi:5476">Candida albicans</span>
Dectin-1 (CLEC7A) is a pattern-recognition receptor expressed by myeloid cells which specifically recognizes beta-(1,3)-glucan, a polysaccharide and component of the fungal cell wall. As a result, dectin-1 is involved in recognition of fungi such as Candida albicans and Aspergillus fumigatus. Upon activation, dectin-1 recruits spleen tyrosine kinase (Syk) which in turn activates NF-kappaB, requiring the adaptor molecule Caspase Activating Recruitment Domain 9 (CARD9), a key adaptor for non-Toll Like Receptor (TLR) signal transduction[7]. Although not the exclusive pathway, CARD9 also has a critical function in NOD2-mediated activation of the kinases p38 and Jnk, required for the production of pro-inflammatory cytokines in innate immune responses to intracellular pathogens[8]. LeibundGut-Landmann et al. showed that dectin-1-Syk-CARD9 signaling induces dendritic cell (DC) maturation and secretion of pro-inflammatory cytokines like interleukin (IL)-6, TNF-alpha, IL-17 and IL-23[9]. Furthermore, Zhernakova et al. identified CARD9 as a susceptibility locus for IBD[10]. Recently, the DECTIN-1 polymorphism c.714T>G on chromosome 12p13 has been described, with a transition from a tyrosine to an early stop codon on amino acid position 238 (p.Y238X)[11]. The functional consequence of this polymorphism is a complete loss-of-function, and immune cells expressing this truncated protein produce significantly less cytokines, including TNF-alpha, IL-1beta and IL-17, upon in vitro stimulation with beta-glucan or Candida albicans[12].
###end p 12
###begin p 13
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Seiderer1">[13]</xref>
###xml 325 328 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-LeibundGutLandmann1">[9]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-vanBeelen1">[14]</xref>
###xml 357 365 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 444 460 444 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 519 538 519 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans is</italic>
###xml 600 624 600 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-StandaertVitse1">[15]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Quinton1">[16]</xref>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 444 460 <span type="species:ncbi:5476">Candida albicans</span>
###xml 519 535 <span type="species:ncbi:5476">Candida albicans</span>
###xml 600 624 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 626 630 <span type="species:ncbi:4932">ASCA</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
Th17 responses are considered to be involved in the pathogenesis of auto-immune diseases. This T cell subset appears to play a role in the etiology of CD since IL-17 is up-regulated in the intestine of IBD patients[13]. Interestingly, both NOD2 and dectin-1 are shown to be capable of inducing Th17 responses after activation[9], [14]. In this respect, the DECTIN-1 c.714T>G polymorphism could influence the Th17 response towards fungi such as Candida albicans, a commensal microorganism of the gastrointestinal tract. Candida albicans is also one of the immunogens for developing antibodies against Saccharomyces cerevisiae (ASCA), which are regularly observed in patients with CD[15], [16].
###end p 13
###begin p 14
###xml 103 119 103 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 103 119 <span type="species:ncbi:5476">Candida albicans</span>
Taking together the data from various studies, a dysregulation of the immune response to the commensal Candida albicans through dectin-1 and IL-17 release might play a role in the pathogenesis of CD.
###end p 14
###begin p 15
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD9</italic>
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 485 493 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 232 236 <span type="species:ncbi:4932">ASCA</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
As stated above, activation of NOD2 and dectin-1 leads to signaling through a shared pathway (CARD9). The importance of this pathway in CD is demonstrated by the fact that mutations in NOD2 and CARD9 and the presence of circulating ASCA, are associated with CD. Since the c.714T>G polymorphism within DECTIN-1 results in a loss of function, we hypothesized that this polymorphism could be potentially protective against developing IBD. Therefore, we aimed to elucidate the role of the DECTIN-1 c.714T>G (p.Tyr238X) polymorphism in patients with IBD, focusing on the occurrence and the clinical severity of IBD.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 17
###begin p 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with a diagnosis of IBD were recruited from the outpatient clinics of three university hospitals in the Netherlands: Radboud University Nijmegen Medical Centre (CD: n = 161, UC: n = 212), VU University Medical Centre Amsterdam (CD: n = 177, UC: n = 148) and the University Medical Centre Groningen (CD: n = 308, UC: n = 214), and one regional hospital: St. Anna Hospital, Geldrop (CD: n = 132, UC: n = 185). Healthy controls were recruited at the Radboud University Nijmegen Medical Centre and at the University Medical Centre Groningen (n = 772).
###end p 18
###begin p 19
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Podolsky1">[17]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Gasche1">[18]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Silverberg1">[19]</xref>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
###xml 580 588 <span type="species:ncbi:9606">patients</span>
Diagnosis of IBD was based on accepted clinical, endoscopic, radiological and histological findings[17]. Clinical data on patients were retrieved by retrospective collection from patients' clinical charts. Clinical data on patients from the VU University Medical Centre were collected prospectively. The following data were obtained from patients with CD: age, age at diagnosis, gender, familial or sporadic IBD, disease localization and behavior of disease (according to the Vienna classification[18]), extra-intestinal manifestations, peri-anal disease, and surgery for CD. For patients with UC, the following data were obtained: age, age at diagnosis, disease location (according to the Montreal classification[19]), familial or sporadic IBD, extra intestinal manifestations, surgery for UC, and occurrence of colorectal cancer.
###end p 19
###begin p 20
###xml 166 173 <span type="species:ncbi:9606">patient</span>
The ethical committee of region Nijmegen and Arnhem reviewed and approved the protocol under number CWOM-nr 9804-0100. Verbal informed consent was obtained from each patient before study participation in agreement with the approval and all samples were anonymized. Given the fact that all research data were anonymously collected, at least verbal informed consent was needed according to national regulations. Therefore, since written informed consent was not required, no written informed consent procedure was introduced at time of data collection.
###end p 20
###begin title 21
Genotyping of c.714T>G polymorphism in DECTIN-1
###end title 21
###begin p 22
###xml 172 180 166 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 193 200 <span type="species:ncbi:9606">patient</span>
###xml 743 750 <span type="species:ncbi:9606">patient</span>
Genomic DNA was isolated from peripheral venous blood using standard techniques and stored at 4degreesC. Genotyping of the c.714T>G (p.Y238X) polymorphism in exon 6 of the DECTIN-1 gene in the patient and healthy control groups from Nijmegen, Amsterdam and Geldrop was performed by applying the predesigned TaqMan SNP assay C_33748481_10 (rs 16910526) on the 7300 ABI Real-Time PCR system (both from Applied Biosystems, Foster City, CA, USA) using 96-well plates. Genotyping of the IBD cohort and healthy controls from Groningen, was performed at the Department of Genetics, UMC Groningen, the Netherlands, applying the same predesigned TaqMan SNP assay, using the 7900 ABI Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). The patient and control DNA samples from Groningen were processed in 384-well plates and each plate also contained 16 genotyping controls (4 duplicates of the Centre d'Etudes du Polymorphisme Humain (CEPH) DNA samples 123002,102405,090203 and 081505). For all polymorphisms we obtained >99.8% concordance between our CEPH genotype data and the CEU (European ancestry) data available from HapMap.
###end p 22
###begin title 23
Genotyping of NOD2 variants
###end title 23
###begin p 24
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Oostenbrug1">[20]</xref>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Data on the three common NOD2 variants were available for CD patients from Groningen and Nijmegen (p.Arg702Trp; n = 437, p.Gly908Arg; n = 446, p.Leu1007ProfsX2; n = 436). Genotyping of these three NOD2 variants (c.2104C>T (p.Arg702Trp), c.2722G>C (p.Gly908Arg), c.3019_3020insC (p.Leu1007ProfsX2)) has been described before[20].
###end p 24
###begin title 25
Immunohistochemical staining
###end title 25
###begin p 26
###xml 218 226 218 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
Dectin-1 and CD68 protein expression were evaluated by immunohistochemical staining in paraffin embedded normal and inflamed colon tissue of five IBD patients and 4 patients with diverticulitis, all homozygous for the DECTIN-1 wild-type allele (T/T). The applied primary antibodies were a monoclonal mouse-anti-human dectin-1 antibody (MAB 1859, purchased from R&D Biosystems, Minneapolis, MN, USA), used in a concentration of 5 microg/ml and a monoclonal mouse-anti-human antibody against CD68 (MCA1815T, purchased from AbD Serotec, Oxford, UK) which was diluted 100 times before use. After overnight incubation with the primary antibody, the tissue sections were incubated for 1 hour with a secondary antibody after washing with PBS. Subsequently the staining was visualized by applying ABC complex and DAB solution. Sections were counterstained with haematoxylin.
###end p 26
###begin title 27
Statistics
###end title 27
###begin p 28
###xml 256 257 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 264 266 262 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 334 342 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 630 634 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 760 764 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 841 849 839 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 897 901 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 905 913 903 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 969 973 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 1010 1014 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 1041 1042 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 740 748 <span type="species:ncbi:9606">patients</span>
###xml 863 871 <span type="species:ncbi:9606">patients</span>
Statistical analysis was performed by using SPSS statistical software, version 16.0 (SPSS Inc., Chicago, IL). Controls and IBD patients were tested for Hardy Weinberg equilibrium. Allele frequencies were compared between patients and controls using the chi2 test. P-values were obtained by comparing individuals carrying at least one DECTIN-1 G allele (G/G genotype and T/G genotype) with wild-type individuals (T/T genotype). Continuous variables were compared using Student t-tests. Strength of association between genotype and phenotype is given as odds ratio with 95% confidence interval (CI). Statistical interaction between NOD2 variants and the c.714T>G polymorphism regarding clinical characteristics, was investigated by comparing patients carrying a NOD2 susceptibility allele in combination with carrying one or two copies of the DECTIN-1 G allele, to patients not bearing any of these NOD2 or DECTIN-1 minor alleles. This combined analysis for c.714T>G and NOD2 was performed for each of the three NOD2 susceptibility alleles. A P-value <0.05 was considered significant.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Protein expression of dectin-1 in intestinal tissue
###end title 30
###begin p 31
###xml 150 158 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007818-g001">Figure 1</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007818-g002">2</xref>
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007818-g001">Figure 1</xref>
###xml 620 628 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007818-g001">Figure 1</xref>
###xml 831 839 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007818-g002">Figure 2</xref>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
###xml 895 903 <span type="species:ncbi:9606">patients</span>
###xml 979 987 <span type="species:ncbi:9606">patients</span>
Dectin-1 and CD68 staining was performed on matched intestinal tissue samples from five IBD patients, either inflamed or non-inflamed, as depicted in Figure 1 and 2. Dectin-1 expression is mainly present on macrophages as showed by staining for CD68 (Figure 1). Furthermore, dectin-1 also appears to be weakly expressed on neutrophils, the membrane of endothelial and epithelial cells and in the submucosal neuronal plexus of Meissner (not shown). Dectin-1 appeared to be up-regulated within inflamed colon tissue due to increased expression of dectin-1 on inflammatory cells and increased influx of inflammatory cells (Figure 1). In order to test whether this increased expression of dectin-1 is IBD specific, additional staining was performed on matched intestinal tissue samples from 4 patients with diverticulitis. As shown in Figure 2, increased expression of dectin-1 was also observed in patients with severe diverticulitis compared to mild diverticulitis. As is true for patients with IBD, expression of dectin-1 is mainly present on macrophages as shown by CD68 staining.
###end p 31
###begin title 32
Representative immunohistochemical staining of DECTIN-1 and CD-68 in inflamed and non-inflamed intestine of the same specimen in Crohn's disease (250x magnified).
###end title 32
###begin p 33
Macrophages are present in non-inflamed intestinal tissue but are present in increased numbers in inflamed tissue (pictures A and C). The expression of DECTIN-1 is increased in inflamed intestinal tissue compared to non-inflamed intestinal tissue (pictures B and D).
###end p 33
###begin title 34
Representative immunohistochemical staining of dectin-1 and CD68 in mild and severe diverticulitis (250x magnified).
###end title 34
###begin p 35
Macrophages are present in intestinal tissue of mild diverticulitis but are present in increased numbers in severe diverticulitis (pictures A and B). Also, the expression of dectin-1 is increased in severe diverticulitis compared to mild diverticulitis (pictures C and D).
###end p 35
###begin title 36
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Distribution of the DECTIN-1 c.714T>G polymorphism in IBD patients and healthy controls
###end title 36
###begin p 37
###xml 77 84 77 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007818-t001">Table 1</xref>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 551 559 551 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 642 650 642 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 757 764 757 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007818-t001">Table 1</xref>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
###xml 476 484 <span type="species:ncbi:9606">patients</span>
Characteristics of the study population and healthy controls are depicted in Table 1. Genotype frequencies of healthy controls were in Hardy Weinberg equilibrium. Carriage of at least one copy of the G allele of the DECTIN-1 polymorphism was 14% in the CD, 14% in the UC and 17% in the healthy control group. The frequency of the G allele was 9.8% in the healthy controls, 8.1% in CD patients and 7.7% in UC patients. Overall, no significant differences were observed between patients with IBD and healthy controls regarding allele frequencies of the DECTIN-1 polymorphism. However, a slight trend towards association of homozygosity for the DECTIN-1 G allele with IBD was observed (G allele frequency of 1.0% in healthy controls vs. 0.5-0.6% in CD and UC, Table 1).
###end p 37
###begin title 38
Distribution of genotypes of wild-type, heterozygous and homozygous individuals for the c.714T>G polymorphism.
###end title 38
###begin p 39
Values are presented as absolute numbers (percentages).
###end p 39
###begin p 40
###xml 25 33 <span type="species:ncbi:9606">patients</span>
*Healthy controls versus patients with IBD; carriers of the mutant allele (T/G and G/G) were compared to wild-types (T/T).
###end p 40
###begin title 41
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Correlation of the DECTIN-1 c.714T>G polymorphism with clinical characteristics of IBD patients
###end title 41
###begin p 42
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007818-t002">Table 2</xref>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 566 573 566 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007818-t003">Table 3</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 313 321 <span type="species:ncbi:9606">Patients</span>
Patients with CD carrying one or two copies of the DECTIN-1 G allele were compared to patients with the wild-type genotype T/T with regard to age at diagnosis, gender, family history of IBD, localization of disease and disease behavior, extra intestinal and peri-anal disease and surgery related to CD (Table 2). Patients with UC were likewise compared according to the DECTIN-1 genotypes regarding age at diagnosis, gender, localization of disease, extra-intestinal disease, development of malignancies, surgery related to UC and a positive family history for IBD (Table 3). No statistical significant associations were observed between the c.714T>G polymorphism and specific phenotypes.
###end p 42
###begin title 43
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Association between DECTIN-1 genotypes and clinical characteristics in a subset of Crohn's disease patients from whom detailed phenotypic data were available (N = 778).
###end title 43
###begin p 44
Values are presented as absolute numbers (percentages).
###end p 44
###begin p 45
*Carriers of the mutant allele (T/G and G/G) were compared to wild-types (T/T).
###end p 45
###begin title 46
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Association between DECTIN-1 genotypes and clinical characteristics in a subset of ulcerative colitis patients from whom detailed phenotypic data were available (N = 759).
###end title 46
###begin p 47
Values are presented as absolute numbers (percentages).
###end p 47
###begin p 48
*Carriers of the mutant allele (T/G and G/G) were compared to wild-types (T/T).
###end p 48
###begin title 49
###xml 97 105 <span type="species:ncbi:9606">patients</span>
The DECTIN-1 c.714T>G polymorphism stratified by NOD2 status and clinical characteristics of IBD patients
###end title 49
###begin p 50
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 435 443 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
CD patients carrying one or two copies of the G allele of the DECTIN-1 gene were stratified by NOD2 status. A NOD2 risk genotype was defined as carrying at least one of the three common NOD2 disease susceptibility alleles (c.2104C>T (p.Arg702Trp), c.2722G>C (p.Gly908Arg), c.3019_3020insC (p.Leu1007ProfsX2)). Combinations of NOD2 risk carriers and DECTIN-1 c.714T>G carriers were compared to patients not bearing any of these NOD2 or DECTIN-1 minor alleles, regarding clinical characteristics. No statistical significant interaction between DECTIN-1 c.714T>G and one of the NOD2 variants was observed (data not shown).
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 320 323 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-LeibundGutLandmann1">[9]</xref>
###xml 325 329 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Ferwerda2">[21]</xref>
###xml 335 343 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
Signaling through dectin-1, known for its recognition of the fungal component beta-glucan, has been described to be involved in several immunological pathways. Dectin-1 amplifies pro-inflammatory cytokine production induced by TLR2 and TLR4, and primes Th1, Th17 and cytotoxic T cell responses induced by dendritic cells[9], [21]. The DECTIN-1 c.714T>G polymorphism results in a loss-of-function of dectin-1, and we hypothesized that this polymorphism could be potentially protective in either the susceptibility to or the disease severity of IBD.
###end p 52
###begin p 53
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Taylor1">[22]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Reid1">[23]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Taylor2">[24]</xref>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 505 510 <span type="species:ncbi:10090">mouse</span>
As shown by immunohistochemical staining of intestinal tissue, dectin-1 is mainly present on macrophages, but also weakly on epithelial and endothelial layers of the intestine. Similar findings in mice have been demonstrated by Wong and co-workers, who demonstrated that dectin-1 is mainly expressed on populations of myeloid cells (monocyte/macrophage and neutrophil lineages)[22]. In addition, they demonstrated that dectin-1 is also expressed in the Peyer's patches and along the lamina propria of the mouse intestine[23], [24]. Interestingly, dectin-1 expression appeared to be elevated in inflamed intestinal tissue compared to normal tissue, due to the increased infiltration of immune cells and increased dectin-1 expression on the cell membrane of immune cells.
###end p 53
###begin p 54
###xml 204 212 <span type="species:ncbi:9606">patients</span>
However, intestinal expression of dectin-1 did not appear to be disease specific but rather dependent on influx of macrophages. In fact, expression of dectin-1 was also present in intestinal samples from patients with diverticulitis. Increased infiltration of macrophages in severe diverticulitis showed an increased expression of dectin-1, compared to mild diverticulitis which is accompanied by less infiltration of macrophages.
###end p 54
###begin p 55
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 353 361 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 505 513 505 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 838 846 835 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 868 872 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Willment1">[25]</xref>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
Cohorts of CD (n = 778) and UC (n = 759) patients were screened for the DECTIN-1 c.714T>G polymorphism and compared to a group of healthy subjects (n = 772). Subsequently, these genetic data were correlated with clinical parameters reflecting disease severity. This analysis revealed no statistical significant association between the prevalence of the DECTIN-1 c.714G allele and IBD, neither in disease occurrence nor in disease severity. However, one can observe that homozygous individuals bearing the DECTIN-1 polymorphism were twice as frequent in healthy controls compared to IBD patients. This may suggest that complete absence of dectin-1 function could protect against IBD. It is important to realize that the only two dectin-1 isoforms capable of binding beta-glucans (isoforms A and B) are structurally equally affected by the DECTIN-1 c.714T>G polymorphism[25]. The occurrence of splicing isoforms with residual function could therefore be excluded. The potential mechanism of protection are likely to include the lower production of pro-inflammatory cytokines, including IL-17, in the individuals with defective dectin-1. In these series, statistical power to preclude any functional difference is insufficient due to the low prevalence of homozygous individuals. Additional studies in homozygous and heterozygous subpopulations are needed to confirm the reported observations.
###end p 55
###begin p 56
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD9</italic>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Underhill1">[26]</xref>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007818-Russell1">[27]</xref>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 431 439 431 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 117 121 <span type="species:ncbi:4932">ASCA</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
All together, the reports of the association of mutations within NOD2 and CARD9 in patients with CD, the presence of ASCA, and the shared signaling pathway of dectin-1 and NOD2, points toward a possible link between NOD2 and dectin-1[26]. Since mutations in NOD2 in CD patients are associated with ileal involvement and increased need for surgery and stricturing disease[27], a potential interaction between NOD2 mutations and the DECTIN-1 c.714T>G polymorphism with regard to phenotypical characteristics was investigated. However, no statistical interaction could be demonstrated (data not shown).
###end p 56
###begin p 57
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DECTIN-1</italic>
Our data demonstrate that dectin-1 expression is elevated on macrophages, neutrophils, and other immune cells involved in the inflammatory reaction in IBD. The DECTIN-1 c.714T>G polymorphism is not a major susceptibility factor for protection against IBD, although a trend towards a lower frequency of the polymorphism in CD and UC cohorts was observed, in particular in the number of individuals homozygous for the DECTIN-1 polymorphism. These genetic findings warrant further investigation of this pathogenetic pathway.
###end p 57
###begin p 58
The authors thank Prof. Cisca Wijmenga (University of Groningen) and Dr. Astrid Oude Lashof for providing DNA of healthy controls.
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
Microbial influences in inflammatory bowel diseases.
###end article-title 60
###begin article-title 61
Unravelling the pathogenesis of inflammatory bowel disease.
###end article-title 61
###begin article-title 62
Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.
###end article-title 62
###begin article-title 63
The genetics of inflammatory bowel disease.
###end article-title 63
###begin article-title 64
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
###end article-title 64
###begin article-title 65
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
###end article-title 65
###begin article-title 66
Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.
###end article-title 66
###begin article-title 67
The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.
###end article-title 67
###begin article-title 68
Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.
###end article-title 68
###begin article-title 69
Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.
###end article-title 69
###begin article-title 70
###xml 14 19 <span type="species:ncbi:9606">human</span>
A family with human dectin-1 deficiency and mucocutanous fungal infections.
###end article-title 70
###begin article-title 71
###xml 27 32 <span type="species:ncbi:9606">human</span>
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
###end article-title 71
###begin article-title 72
Role of the novel th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.Hisl6lArg polymorphism in IBD.
###end article-title 72
###begin article-title 73
###xml 120 125 <span type="species:ncbi:9606">human</span>
Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.
###end article-title 73
###begin article-title 74
###xml 0 16 <span type="species:ncbi:5476">Candida albicans</span>
###xml 42 66 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
###end article-title 74
###begin article-title 75
###xml 5 29 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
###end article-title 75
###begin article-title 76
Inflammatory bowel disease.
###end article-title 76
###begin article-title 77
A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998.
###end article-title 77
###begin article-title 78
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
###end article-title 78
###begin article-title 79
CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: An association study and pooled analysis.
###end article-title 79
###begin article-title 80
###xml 66 71 <span type="species:ncbi:9606">human</span>
Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages.
###end article-title 80
###begin article-title 81
The beta-glucan receptor, dectin-1, is predominantly expressed on the, surface of cells of the monocyte/macrophage and neutrophil lineages.
###end article-title 81
###begin article-title 82
###xml 53 59 <span type="species:ncbi:10090">murine</span>
Expression of the beta-glucan receptor, dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions.
###end article-title 82
###begin article-title 83
The beta-glucan receptor, dectin-1, is predominantly expressed on the, surface of cells of the monocyte/macrophage and neutrophil lineages.
###end article-title 83
###begin article-title 84
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human beta -glucan receptor and its alternatively spliced isoforms.
###end article-title 84
###begin article-title 85
Current understanding of fungal microflora in inflammatory bowel disease pathogenesis.
###end article-title 85
###begin article-title 86
Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARDI 5 variants consistently predict phenotypic characteristics of severe disease.
###end article-title 86
###begin p 87
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 87
###begin p 88
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: M.G.N. was supported by a Vidi grant of the Netherlands Organization for Scientific Research. T.S.P. was supported by TI-Pharma Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 88

